Morrison Maureen F
Known title: DirectorCIK: 0001720970
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
ePlus mentioned in recent Yahoo service stock analysis. Yahoo’s latest service‑sector review included ePlus among the stocks evaluated. The commentary placed the company in a group of firms with competitive advantages, while also noting broader headwinds for the sector. This coverage adds analyst focus to ePlus as it trades near the upper end of its 52‑week range.
Transaction History
| ABG | ▲ Buy | Grant | 932 | $0 | 2/9/2026 | View on chart |
| PLUS | ▲ Buy | Grant | 1,478 | $0 | 10/1/2025 | View on chart |
| ABG | ▼ Sell | Open Market | 800 | $204K | 8/28/2025 | View on chart |
| ABG | ▲ Buy | Grant | 713 | $0 | 2/19/2025 | View on chart |
| PLUS | ▲ Buy | Grant | 1,067 | $0 | 10/1/2024 | View on chart |
| ABG | ▲ Buy | Grant | 968 | $0 | 2/20/2024 | View on chart |
| PLUS | ▲ Buy | Grant | 1,353 | $0 | 9/25/2023 | View on chart |
| PLUS | ▲ Buy | Grant | 2,052 | $0 | 9/26/2022 | View on chart |
| ABG | ▲ Buy | Grant | 731 | $0 | 2/16/2022 | View on chart |
| ABG | ▲ Buy | Grant | 667 | $0 | 2/14/2022 | View on chart |
| PLUS | ▲ Buy | Grant | 787 | $0 | 9/27/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
ABG Analysts Cut Targets Amid Mega-Dealership Strategy Shift
ABG announced a focus on mega‑dealership investments to sharpen its competitive position. Several banks, including UBS, JP Morgan, Barclays and Morgan Stanley, have lowered their price targets to the $184‑$230 range. The company also scheduled a release of its third‑quarter 2026 results. The stock is trading near a key support level at $210.55 and shows a weak RSI of 29.4.
ABG Analysts Cut Targets Amid Mega-Dealership Strategy Shift. ABG announced a focus on mega‑dealership investments to sharpen its competitive position. Several banks, including UBS, JP Morgan, Barclays and Morgan Stanley, have lowered their price targets to the $184‑$230 range. The company also scheduled a release of its third‑quarter 2026 results. The stock is trading near a key support level at $210.55 and shows a weak RSI of 29.4.